Abstract
The coordination chemistry of palladium is poorly developed in nuclear medicine due to the lack of appropriate ligands capable of fulfilling all the criteria required for an in vivo application. By showing that the monopicolinate cyclam TE1PA is a highly relevant chelator for natural and radioactive Pd, we have opened avenues to enrich the area of palladium-based targeted radiotherapies. This cover represents the early stage of their expansion. More information can be found in the Research Article by C. H. S. Driver, N. Le Bris, R. Tripier, and co-workers (DOI: 10.1002/chem.202200942).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
